BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dupont CA, Riegel K, Pompaiah M, Juhl H, Rajalingam K. Druggable genome and precision medicine in cancer: current challenges. FEBS J 2021. [PMID: 33626231 DOI: 10.1111/febs.15788] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Beis G, Serafeim A, Papasotiriou I. Data-driven analysis and druggability assessment methods to accelerate the identification of novel cancer targets. Computational and Structural Biotechnology Journal 2023;21:46-57. [DOI: 10.1016/j.csbj.2022.11.042] [Reference Citation Analysis]
2 Zhang P, Tu S, Zhang W, Xu L. Predicting cell line-specific synergistic drug combinations through a relational graph convolutional network with attention mechanism. Brief Bioinform 2022;23:bbac403. [PMID: 36136353 DOI: 10.1093/bib/bbac403] [Reference Citation Analysis]
3 Wang S, Wang H, Zhu S, Li F. Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1040892] [Reference Citation Analysis]
4 Perillat L, Mercuri M. Clinical recommendations: The role of mechanisms in the GRADE framework. Stud Hist Philos Sci 2022;96:1-9. [PMID: 36126546 DOI: 10.1016/j.shpsa.2022.08.018] [Reference Citation Analysis]
5 Capuano N, Foggia P, Greco L, Ritrovato P. A Linked Data Application for Harmonizing Heterogeneous Biomedical Information. Applied Sciences 2022;12:9317. [DOI: 10.3390/app12189317] [Reference Citation Analysis]
6 Wang Y, Zhu H, Wang X. Prognosis and immune infiltration analysis of endoplasmic reticulum stress-related genes in bladder urothelial carcinoma. Front Genet 2022;13:965100. [DOI: 10.3389/fgene.2022.965100] [Reference Citation Analysis]
7 Weagel EG, Foulks JM, Siddiqui A, Warner SL. Molecular glues: enhanced protein-protein interactions and cell proteome editing. Med Chem Res. [DOI: 10.1007/s00044-022-02882-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Guan Z, Liu S, Luo L, Wu Z, Lu S, Guan Z, Tao K. Identification of Ferroptosis-Related Genes as Biomarkers for Sarcoma. Front Cell Dev Biol 2022;10:847513. [PMID: 35309947 DOI: 10.3389/fcell.2022.847513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kitazawa S, Ohno T, Haraguchi R, Kitazawa R. Histochemistry, Cytochemistry and Epigenetics. Acta Histochem Cytochem 2022;55:1-7. [PMID: 35444348 DOI: 10.1267/ahc.21-00095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Seyhan AA. The Current State of Precision Medicine and Targeted-Cancer Therapies: Where Are We? Drug Target Selection and Validation 2022. [DOI: 10.1007/978-3-030-95895-4_7] [Reference Citation Analysis]
11 Rocca A, Kholodenko BN. Can Systems Biology Advance Clinical Precision Oncology? Cancers (Basel) 2021;13:6312. [PMID: 34944932 DOI: 10.3390/cancers13246312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Watson CJ. The ever-expanding landscape of cancer therapeutic approaches. FEBS J 2021;288:6082-6. [PMID: 34719877 DOI: 10.1111/febs.16228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Riegel K, Yurugi H, Schlöder J, Jonuleit H, Kaulich M, Kirschner F, Arnold-Schild D, Tenzer S, Schild H, Rajalingam K. ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppression. Cell Death Dis 2021;12:969. [PMID: 34671021 DOI: 10.1038/s41419-021-04257-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang S, Chen S, Ying Y, Ma X, Shen H, Li J, Wang X, Lin Y, Liu B, Zheng X, Xie L. Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma. Front Cell Dev Biol 2021;9:676142. [PMID: 34291048 DOI: 10.3389/fcell.2021.676142] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]